Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Inoviq Ltd

IIQ
Current price
0.45 AUD -0.005 AUD (-1.11%)
Last closed 0.46 AUD
ISIN AU0000196149
Sector Healthcare
Industry Diagnostics & Research
Exchange Australian Securities Exchange
Capitalization 49 078 991 AUD
Yield for 12 month -25.83 %
1Y
3Y
5Y
10Y
15Y
IIQ
21.11.2021 - 28.11.2021

INOVIQ Ltd engages in the developing and commercializing of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. Its cancer diagnostic pipeline includes internal and partnered diagnostic tests for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia. Address: 23 Normanby Road, Notting Hill, VIC, Australia, 3168

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.26 AUD

P/E ratio

Dividend Yield

Current Year

+535 196 AUD

Last Year

+398 251 AUD

Current Quarter

+681 851 AUD

Last Quarter

+681 851 AUD

Current Year

-989 966 AUD

Last Year

-1 040 173 AUD

Current Quarter

-700 284 AUD

Last Quarter

-700 284 AUD

Key Figures IIQ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -5 643 576 AUD
Operating Margin TTM -259.14 %
PE Ratio
Return On Assets TTM -19.7 %
PEG Ratio
Return On Equity TTM -33.1 %
Wall Street Target Price 5.26 AUD
Revenue TTM 1 561 788 AUD
Book Value 0.19 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -1.7 %
Dividend Yield
Gross Profit TTM -1 717 998 AUD
Earnings per share -0.07 AUD
Diluted Eps TTM -0.07 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IIQ

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IIQ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:30
Payout Ratio
Last Split Date 01.12.2020
Dividend Date

Stock Valuation IIQ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 75.2026
Price Sales TTM 32.8533
Enterprise Value EBITDA -3.2264
Price Book MRQ 2.4553

Financials IIQ

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IIQ

For 52 weeks

0.43 AUD 0.92 AUD
50 Day MA 0.48 AUD
Shares Short Prior Month
200 Day MA 0.55 AUD
Short Ratio
Shares Short
Short Percent